Siena, Italy

Marzia Monica Guiliani

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marzia Monica Guiliani. Retrieved from https://idiyas.com/inventor/marzia-monica-guiliani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marzia Monica Guiliani: Innovator in Neisserial Protein Expression

Introduction

Marzia Monica Guiliani is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of biotechnology, particularly in the area of protein expression. Her innovative approaches have the potential to enhance the development of vaccines and diagnostics.

Latest Patents

Marzia holds a patent titled "Heterologous expression of Neisserial proteins - Alternative and improved approaches to the heterologous expression of the proteins." This patent focuses on methods that improve the level of expression, ease of purification, cellular localization, and immunological properties of expressed proteins. She has 1 patent to her name.

Career Highlights

Throughout her career, Marzia has worked with notable companies such as Novartis AG and Novartis Vaccines and Diagnostics Srl. Her work in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in medical science.

Collaborations

Marzia has collaborated with esteemed colleagues, including Maria Arico and Maurizio Comanducci. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Marzia Monica Guiliani's contributions to the field of protein expression exemplify her dedication to innovation in biotechnology. Her work continues to influence the development of effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…